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The lung disease of Cystic Fibrosis (CF) is characterized by a vicious cycle of
infection and inﬂammation. Both processes appear to be present in the lower respi-
ratory tract (LRT) from an early age in individuals with CF. Previous studies have
identiﬁed a number of pathogens in LRT specimens obtained from infants with CF
but have relied upon the culture of such organisms on general microbiological
media. The limitations of culture-based microbiology are now well established
and as such, molecular methodologies are required to thoroughly characterize the
microbial community present within a given sample. The total microbial community
of the CF infant lung is largely unknown at present. A thorough understanding
of this community is likely to result in improved protocols for the treatment
of CF patients in infancy. Bronchoalveolar lavage ﬂuid (BALF) specimens were
obtained from infants (<12 months of age) with CF. Nucleic acids were extracted,
bacterial 16S rRNA ampliﬁed through PCR and PCR products analysed using Ter-
minal Restriction Length Polymorphism (T-RFLP). T-RFLP bands were identiﬁed
that corresponded to a range of organisms, including Pseudomonas aeruginosa,
Haemophilus inﬂuenzae, Alcaligenes spp. and Streptococcus spp. These ﬁndings
challenge the current accepted view that P. aeruginosa is only present in the CF
lung in a minority of infants and and that a limited number of distinct pathogens
are present in the LRT.
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Recently it has been shown that the lungs of CF patients are not colonized only
by commonly recognized bacteria, such as Ps.aeruginosa, but also by a range of
potentially pathogenic anaerobic species.
Aim: was to describe the bacterial communities present in sputum of CF children
by the gas chromatography and mass spectrometry (GC-MS) method.
Method: Sputum samples were collected from 35 CF patients, 6−17 years old, 17
m. Microbial cellular fatty acids were extracted by chemical procedure and analyzed
by GC-MS.
Results: The algorithm of mass spectrometric parameters was developed, which
permitted the determination of about 200 known microbial fatty acids, aldehy-
des and sterols, sufﬁcient for the detection and quantitative determination of
more that 150 taxons of clinically signiﬁcant mucosa microorganisms without
precultivation. The participation of 47 microbial taxons, including some fungi
and viruses, in the process was conﬁrmed. Anaerobes from a range of species
including Eubacterium (E.moniliforme, E.nodatum, E.sabureum, E.lentum), Propi-
onibacterium freudenreichii, Clostridium ramosum, Actinomyces, Eggertella were
detected in high numbers (3×109 cells/ml, 1.4×109 cells/ml, 4×108 cells/ml,
4×108 cells/ml, 1×108 cells/ml, 1×107 cells/ml, respectively). In comparison:
St.aureus and Ps.aeruginosa – 4.8×107 cells/ml). The concentration of other anaer-
obes (Bacteroides, Porphyromonas, Prevotella), mentioned as potentially signiﬁcant
in previous works, was not clinically important in our patients.
Conclusion: Such anaerobes as Eubacterium, Propionibacterium freudenreichii,
Clostridium, Actinomyces and Eggertella could play a clinical role to CF patients.
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Burkholderia cepacia complex (Bcc) has been suggested as important pathogens in
lung disease of Cystic Fibrosis (CF) patients, and selective medium is necessary for
their recovery specially in patients harboring mucoid P. aeruginosa.We evaluate the
effectiveness of a home made selective medium modiﬁed from BCSA original for-
mulation, as an option for locations that have limited resources. From January 2005
to January 2008 we analyzed 1368 sputum and oropharyngeal secretion samples,
from 216 CF patients attending the outpatient Pediatric CF reference center from the
State University Hospital, Unicamp, Brazil. The BCSA agar original formulation
was modiﬁed using only 2.5mg/L of vancomycin and 600.000U of injectable
Colistin as selective antibiotics and keeping the other reagents. P. aeruginosa ATCC
27853, B. cepacia ATCC 25416 were used for quality control. From January 2005 to
October 2006 we detected 8/152 (5.2%) patients with Bcc without selective medium,
6 cases chronic and 2 with a single sample. In next period from November 2006
to September 2007 with the modiﬁed selective BCSA medium, 7 new cases were
detected and the previous 5 Bcc chronic infection patients (one of the 6 chronic
patients died), 12/153 (7.84%). In the 3rd period from September 2007 to January
2008 we compared the standard BCSA OXOID® and the modiﬁed BCSA for 112
patients and only one new patient was detected in both media. These results conﬁrm
the effectiveness of the modiﬁed selective medium, easy preparation, low cost and
the usefulness in microbiology routine for CF patients.
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Preserved isolates from 1994 to 2007 of Burkholderia species from 47 Danish
patients from two Centers were investigated (one isolate per patient). Speciﬁc iden-
tiﬁcation of 46 isolates was perfomed by partial sequencing of two housekeeping
genes. Comparison of either atpD or recA sequences with reference strains gave
identical results. Forty isolates were identiﬁed as B. multivorans, two isolates as
B. cenocepacia, two as [B. cenocepacia] genomovar IIIB, and one as B. anthina.
The last isolate was identiﬁed as B. gladioli by 16S rDNA sequence. Genotyping
by PFGE revealed little cross-infection among Danish CF patients.
Only 4 isolates (9%) were classiﬁed as B. cenocepacia/genomovar III, whereas
85% of the isolates were classiﬁed as B. multivorans. This species distribution
is in contrast with reports from other CF centers in Europe and North America,
where clones of B. cenocepacia and occasionally B. cepacia have spread among
patients. A preponderance of B. multivorans among patients with CF may represent
the sporadic acquisition of Burkholderia strains from the environment, at least in
Denmark.
Supported by: Danish Cystic Fibrosis Association.
